SCHEMBL6427351

SCHEMBL6427351

O=C(CC1SC(Nc2ccccc2)=NC1=O)Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
MAPT P10636 8/20 0.51
KMT2A Q03164 6/20 0.51
GAA P10253 5/20 0.51
HPGD P15428 3/20 0.51
ADAM17 P78536 1/20 0.51
KDM4E B2RXH2 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 4/20 0.49
MAP2K1 Q02750 1/20 0.48
NSD2 O96028 1/20 0.47
CYP2C19 P33261 1/20 0.47
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
POLB P06746 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
EPHX2 P34913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6505857 0.87 MAPT (0.45) ALDH1A1MAPTKMT2AGAAHPGD
SCHEMBL1606815 0.87 MAPT (0.47) ALDH1A1MAPTKMT2AGAAHPGD
SCHEMBL6390197 0.87 ALDH1A1 (0.53) ALDH1A1MAPTKMT2AGAAHPGD
SCHEMBL6388541 0.87 MAPT (0.46) ALDH1A1MAPTKMT2AGAAHPGD
SCHEMBL14285640 0.84 KMT2A (0.65) ALDH1A1MAPTKMT2AGAAHPGD
SCHEMBL14173449 0.83 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AGAAHPGD
SCHEMBL6390081 0.80 MAPT (0.49) ALDH1A1MAPTKMT2AGAAHPGD
SCHEMBL14449493 0.80 KMT2A (0.53) ALDH1A1MAPTKMT2AGAAKDM4E
SCHEMBL6388731 0.80 ALDH1A1 (0.54) ALDH1A1MAPTKMT2AGAAHPGD
SCHEMBL6428167 0.79 HSP90AA1 (0.39) ALDH1A1KMT2AHPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US claimed
WO-2005075471-A2 THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS BIOVITRUM AB (SE) 2005-08-18 WO claimed
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US disclosed
WO-2005075471-A2 THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS BIOVITRUM AB (SE) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239853-A1 New compounds HSD11B1, CYP11B1, HSD3B1 ALDH1A1 67/4885MAPT 3607/4885KMT2A 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.